Skip to content
Home/Companies/MedTech/Eurobio Scientific
Eurobio Scientific

Eurobio Scientific

MedTech·France·Active·2yr hold
Entry
2024
Hold
2yr
Status
Active

Who owns Eurobio Scientific?

Eurobio Scientific is a French MedTech company, currently owned by Cèdre Capital since 2025 and IK Partners. It changed hands in 2024, when NextStage AM sold.

Hand-verified · 3 sources · updated 2026-09-30

Open JSON · CC-BY
IK Partners
Most recent investor
IK Partners
IK X (Mid Cap) · 2024 · Buyout
3 ownership periods · full history below

Key facts

HQFrance
SectorMedTech

Ownership history

3 ownership periods · co-invest detected

Active
Co-held by IK Partners and Cèdre Capital since 2024.
NextStage AM
NextStage AMExited 2024
2022 · 2024(2yr) · Pepites & Territoires by AXA · 2021 · Growth
Recapitalization · to EB Development / IK Partners

NextStage AM sold Eurobio Scientific to EB Development / IK Partners in 2024 after 2 years.

Co-invest · 2 holders · 2024 · present
IK Partners
2024 · present(2yr) · IK X (Mid Cap) · 2024 · Buyout
Cèdre Capital
2025 · present(1yr) · Cèdre Capital Evergreen · 2010 · VC

Questions

Who owns Eurobio Scientific?

Eurobio Scientific is currently owned by Cèdre Capital and IK Partners, through IK X (Mid Cap), since 2025.

When did Cèdre Capital and 1 other acquire Eurobio Scientific?

Cèdre Capital and 1 other acquired Eurobio Scientific in 2025.

Who did Eurobio Scientific sell to?

NextStage AM sold Eurobio Scientific to EB Development / IK Partners in 2024 (Recapitalization).

Who has owned Eurobio Scientific over time?

Eurobio Scientific has been through 3 private-equity ownership periods: NextStage AM · via Pepites & Territoires by AXA · 2022–2024 · sold to EB Development / IK Partners · (Recapitalization); IK Partners · via IK X (Mid Cap) · since 2024; Cèdre Capital · via Cèdre Capital Evergreen · since 2025.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue